How many studies have been conducted on Erythromycin?

BiohacksAI has indexed 296 PubMed studies on Erythromycin, including 7 randomized controlled trials (RCTs). 14% of studies involve human subjects.

What are the main research areas for Erythromycin?

The primary research domains for Erythromycin are 🫁 Liver & Detox, 🦠 Gut & Microbiome, 🫁 Respiratory. This is based on analysis of 296 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Erythromycin

A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.

296+ PubMed studies analyzed · 7 RCTs · Evidence Score: 40.7

Research Domains

Erythromycin has been studied across 8 research domains including 🫁 Liver & Detox, 🦠 Gut & Microbiome, 🫁 Respiratory, 🫘 Kidney, 😴 Sleep. The primary research focus is 🫁 Liver & Detox with 7% of studies addressing this area.

Loading evidence profile...

This evidence profile for Erythromycin is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.